DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Glenmark Pharmaceuticals Limited — Analyst/Investor Meet Para A-XBRL

NSE 18 hrs ago·6 Nov 2026, 8:07 am

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals has informed stock exchanges that it has implemented audio and video recording facilities for its upcoming analyst and investor meetings. This measure is part of the company's broader initiative to enhance transparency and ensure accurate documentation of all discussions held during these sessions.

For investors, this development signals a commitment to better governance and clearer communication. It helps prevent any misinterpretation of management guidance or financial outlooks shared during the meetings, providing a reliable record for all stakeholders to review later.

Investors should monitor the details shared during these recorded sessions, particularly regarding the company's pipeline and financial targets. The availability of these records will allow for a more thorough analysis of management's long-term strategy and current performance.